Dallas, TX -- (SBWIRE) -- 03/22/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
ACCO Brands Corporation(NYSE:ACCO) shares declined 2.79% and closed at $6.97. The company, on Mar. 6, announced that James "Jay" Mitchell has been named senior vice president, ACCO Brands and president, ACCO Brands Europe, with full responsibility for the general management of the company's European business. The appointment is effective immediately. Most recently, Mitchell was senior vice president, Operations, ACCO Brands International, overseeing European operations.
Get Latest News, Updates on ACCO Here
Opko Health Inc.(NYSE:OPK) shares fell 2.78% and closed at $7.35. The company on March 7 agreed to sell its in RNA interference research products to RXi Pharmaceuticals Corp., prompting investors to push its stock to a new high.
Additionally, the company, on March 4 announced that it has completed the acquisition of Cytochroma Inc. (Markham, Canada). Cytochroma`s lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.
Is OPK a Strong Buying Opportunity After The Recent Slump? Find out Here
CYS Investments Inc(NYSE:CYS) shares decreased 0.09% to $11.63 in the last trading session. The Board of Directors of CYS Investments on Mar. 8 declared a quarterly dividend of $0.32 per share of common stock for the first quarter of 2013. The common stock dividend will be paid on April 17, 2013 to common stock stockholders of record on March 25, 2013.
Additionally, the company will begin trading ex-dividend on March 21, 2013. A cash dividend payment of $0.32 per share is scheduled to be paid on April 17, 2013. Shareholders who purchased CYS stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an -65.22% decrease from the prior quarter.
Is CYS Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Southwestern Energy Company (NYSE:SWN) stock decreased 2.75% to $37.79. SWN’s stock had its price target upped by RBC Capital from $39.00 to $44.00 in a research note released on Mar. 19. They currently have an outperform rating on the stock.
Additionally, the company, on Feb. 20, reported fourth-quarter net loss of $355.6 million or $1.02 per share, compared with net income of $158.5 million or $0.45 per share last year. Adjusted earnings for the quarter were $156.4 million or $0.44 per share. Analysts on consensus estimated earnings of $0.44 per share for the quarter. The company reported fourth-quarter revenues of $773 million, compared with $744 million a year ago. Analysts estimated revenues of $712.60 million.
Is SWN Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com
Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)